Skip to main content
Fig. 5 | Orphanet Journal of Rare Diseases

Fig. 5

From: Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database

Fig. 5

Demographics and baseline characteristics of patients with facial angiofibroma by the use of topical mTOR inhibitors. aData was available for 1238 patients (Patients using topical mTOR inhibitor, N = 309; Patients not using topical mTOR inhibitor, N = 929). *p < 0.05; ** < 0.01; ***p ≤ 0.001; ****p < 0.0001. ADHD, Attention-deficit/hyperactivity disorder; CI, confidence interval; FA, facial angiofibroma; mTOR, mechanistic target of rapamycin, OR, odds ratio; SD, standard deviation; SEGA, subependymal giant cell astrocytoma; TSC, tuberous sclerosis complex

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172